FDA OKs New Infection Drugs

A new antibacterial drug and an anti-influenza medication got the nod from the FDA. The agency approved the combination of ceftolozane, a cephalosporin antibacterial drug, and tazobactam, a beta-lactamase inhibitor, which will be sold as Zerbaxa and used to treat complicated intra-abdominal infections and complicated urinary tract infections. And it also approved peramivir (Rapivab), an anti-influenza drug delivered by intravenous injection and intended for patients unable to take medication orally or by inhalation. http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/49269?xid=nl_mpt_DHE_2014-12-23&utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=ST&eun=g721819d0r&userid=721819&email=amydugan2%40gmail.com&mu_id=5883165&utm_term=Daily